Thermotherapy Against Persistent Bacterial LUNG Infections
Launched by CHRONIC OBSTRUCTIVE PULMONARY DISEASE TRIAL NETWORK, DENMARK · Apr 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called thermotherapy to see if it can help reduce harmful bacteria in the lungs of people with chronic lung infections. The goal is to find out if spending time in a sauna—where the temperature is very high—can help clear out these bacteria, which are often hard to treat with antibiotics. The study is open to adults aged 18 and older who have had positive tests for specific bacteria in their lung samples at least twice in the last two years, even after antibiotic treatment.
Participants in the study will be asked to use a sauna at least four times a week for six months, with each session lasting at least seven minutes. This trial is currently looking for volunteers, and it's important to know that there are some health conditions that may prevent someone from joining, such as severe allergies or certain mental health issues. Overall, this research could provide new insights into how to treat persistent lung infections more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Competent and capable
- • FEV1\>1,0 L
- • Have had a positive culture from sputum or BAL min. 2 times in the last 24 months for bacteria of the species: Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, Haemophilus influenzae, Achromobacter xylosoxidans, Klebsiella oxytoca or Klebsiella pneumoniae. In addition, min. 1 positive culture after treatment with antibiotics
- • Willing to go to a sauna (min. temperature of 85℃ for at least 7 minutes) four times weekly for six months or avoid going to a sauna for six months
- Exclusion Criteria:
- • Allergy to lidocaine and/or midazolam
- • Contraindications to bronchoscopy
- • Previous severe laryngospasm (intubation requiring)
- • Pregnancy/breastfeeding
- • Severe linguistic problems or inability to give informed consent
- • Severe mental illness that is not controlled with medication. NB: Patients with controlled mental illness can be included and will be asked on an equal footing as others
About Chronic Obstructive Pulmonary Disease Trial Network, Denmark
The Chronic Obstructive Pulmonary Disease (COPD) Trial Network in Denmark is a dedicated research consortium focused on advancing the understanding and treatment of COPD through innovative clinical trials. Comprising a multidisciplinary team of healthcare professionals, researchers, and industry partners, the network aims to facilitate high-quality, evidence-based studies that address critical gaps in COPD management. By leveraging Denmark's robust healthcare system and commitment to research excellence, the network seeks to enhance patient outcomes and inform clinical practice through the development of new therapeutic interventions and strategies tailored to the unique needs of individuals living with COPD.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hellerup, Region Hovedstaden, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials